SEC Form 4 · accession 0001082038-15-000004
DURECT CORP · DRRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Su Il Yum
Officer — Exec. VP Pharm./R&D
Period of report
Jan 9, 2015
Accepted (ET)
Jan 13, 2015 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $0.88 | Jan 9, 2015 | A | 64,452 | A | Apr 9, 2015 | Jan 9, 2025 | Common Stock | 64,452 | 64,452 | D |
| Non-Qualified Stock Option (right to buy)F2 | $0.88 | Jan 9, 2015 | A | 70,512 | A | Jan 9, 2015 | Jan 9, 2025 | Common Stock | 70,512 | 70,512 | D |
| Non-Qualified Stock Option (right to buy)F1 | $0.88 | Jan 9, 2015 | A | 15,548 | A | Apr 9, 2015 | Jan 9, 2025 | Common Stock | 15,548 | 86,060 | D |
Explanation of responses
- F1ISO/NQ Grants Dated January 9, 2015 combined will vest as follows: one-sixteenth (1/16) of the total shares subject to the option shall vest quarterly over four (4) years following the Grant Date.
- F2100% of the total shares of this Grant Dated January 9, 2015 shall vest on the Grant Date.